HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Noninvasive delayed limb ischemic preconditioning attenuates myocardial ischemia-reperfusion injury in rats by a mitochondrial K(ATP) channel-dependent mechanism.

Abstract
We previously demonstrated in rats that noninvasive delayed limb ischemic preconditioning (LIPC) induced by three cycles of 5-min occlusion and 5-min reperfusion of the left hind limb per day for three days confers the same cardioprotective effect as local ischemic preconditioning of the heart, but the mechanism has not been studied in depth. The aim of this project was to test the hypothesis that delayed LIPC enhances myocardial antioxidative ability during ischemia-reperfusion by a mitochondrial K(ATP) channel (mito K(ATP))-dependent mechanism. Rats were randomized to five groups: ischemia-reperfusion (IR)-control group, myocardial ischemic preconditioning (MIPC) group, LIPC group, IR-5HD group and LIPC-5HD group. The MIPC group underwent local ischemic preconditioning induced by three cycles of 5-min occlusion and 5-min reperfusion of the left anterior descending coronary arteries. The LIPC and LIPC-5HD groups underwent LIPC induced by three cycles of 5-min occlusion and 5-min reperfusion of the left hind limb using a modified blood pressure aerocyst per day for three days. All rats were subjected to myocardial ischemia-reperfusion injury. The IR-5HD and LIPC-5HD groups received the mito K(ATP) channel blocker 5-hydroxydecanoate Na (5-HD) before and during the myocardial ischemia-reperfusion injury. Compared with the IR-control group, both the LIPC and MIPC groups showed an amelioration of ventricular arrhythmia, reduced myocardial infarct size, increased activities of total superoxide dismutase, manganese-superoxide dismutase (Mn-SOD) and glutathione peroxidase, increased expression of Mn-SOD mRNA and decreased xanthine oxidase activity and malondialdehyde concentration. These beneficial effects of LIPC were prevented by 5-HD. In conclusion, delayed LIPC offers similar cardioprotection as local IPC. These results support the hypothesis that the activation of mito K(ATP) channels enhances myocardial antioxidative ability during ischemia-reperfusion, thereby contributing, at least in part, to the anti-arrhythmic and anti-infarct effects of delayed LIPC.
AuthorsY-N Wu, H Yu, X-H Zhu, H-J Yuan, Y Kang, J-J Jiao, W-Z Gao, Y-X Liu, J-S Lou
JournalPhysiological research (Physiol Res) Vol. 60 Issue 2 Pg. 271-9 ( 2011) ISSN: 1802-9973 [Electronic] Czech Republic
PMID21114361 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Decanoic Acids
  • Hydroxy Acids
  • Potassium Channel Blockers
  • Potassium Channels
  • mitochondrial K(ATP) channel
  • Malondialdehyde
  • 5-hydroxydecanoic acid
  • Glutathione Peroxidase
  • Superoxide Dismutase
  • Xanthine Oxidase
Topics
  • Animals
  • Arrhythmias, Cardiac (drug therapy, prevention & control)
  • Decanoic Acids (pharmacology)
  • Glutathione Peroxidase (biosynthesis)
  • Hydroxy Acids (pharmacology)
  • Ischemic Preconditioning (methods)
  • Male
  • Malondialdehyde (metabolism)
  • Myocardial Infarction (drug therapy, prevention & control)
  • Myocardial Reperfusion Injury (drug therapy, prevention & control)
  • Myocardium (chemistry, metabolism)
  • Potassium Channel Blockers (pharmacology)
  • Potassium Channels (drug effects, metabolism)
  • Rats
  • Rats, Wistar
  • Superoxide Dismutase (biosynthesis)
  • Xanthine Oxidase (biosynthesis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: